<DOC>
	<DOCNO>NCT01466686</DOCNO>
	<brief_summary>To evaluate safety effectiveness low dose rate radiation therapy plus temozolomide . This patient High Grade Glioma ( include Anaplastic Astrocytoma Glioblastoma Multiforme ) previously treat surgery follow radiation surgical resection follow adjuvant radiation therapy plus temozolomide .</brief_summary>
	<brief_title>Low Dose Radiation Therapy Glioblastoma Multiforme</brief_title>
	<detailed_description>In vitro vivo study suggest low dose fractionate radiation therapy ( LDFRT ) may use potentiate full dose chemotherapy , decrease development resistance find standard dos radiation chemotherapy . This nonrandomized , open label , single institution phase II trial safety run-in evaluate safety efficacy LDFRT plus temozolomide patient High Grade Glioma ( include Anaplastic Astrocytoma Glioblastoma Multiforme ) previously treat surgical resection follow adjuvant radiation therapy plus temozolomide . The primary objective phase II study estimate response rate patient treat twice daily fraction low dose radiation plus temozolomide chemotherapy .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Patients must recurrent GBM ( Glioblastoma Multiforme ) Anaplastic Astrocytoma . The diagnosis GBM Anaplastic Astrocytoma . Patients must previously treat surgical resection ( extent okay ) adjuvant radiation therapy plus temozolomide . Patients must least 12 month completion radiation therapy At least 2 month completion temozolomide ( consistent `` rechallenge '' group Perry et al . JCO 2010 ) . Age &gt; 18 year ECOG performance status &lt; 2 ( Karnofsky &gt; 60 % , see appendix A ) . There must measurable disease MRI . Patients must normal organ marrow function define : Women must pregnant Ability understand willingness sign write informed consent document Temozolomide retreatment plan treat neurooncologist . The recent brain tumor pathology obtain patient must glioblastoma . Must able receive MRI Patients may receive investigational cancer treatment agent time enrollment . Patients may previously fail treatment salvage temozolomide . Patients may previously fail treatment VEGF inhibitor . Patients may previously treat &gt; 1 course radiotherapy . Patients may previously treat radiosurgery brain . Uncontrolled intercurrent illness Pregnant breastfeed woman exclude . Women childbearing potential unwilling unable use acceptable method birth control avoid pregnancy entire study period 12 week study exclude . Male subject must also agree use effective contraception period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Recurrent Glioblastoma Multiforme</keyword>
	<keyword>Recurrent Anaplastic Astrocytoma</keyword>
	<keyword>Surgery</keyword>
	<keyword>Adjuvant Radiation</keyword>
	<keyword>Adjuvant Temozolomide</keyword>
</DOC>